Aspirin in Primary CVD Prevention: Risks Outweigh Benefits

And for how long have we been told to take an aspirin a day?

A new meta-analysis said to provide "the largest evidence to date regarding the wider effects of aspirin treatment in primary prevention" has shown that cardiovascular benefits are offset by an elevated risk of bleeding.

Senior author Dr Kausik Ray (St George's University of London, UK) commented to heartwire : "On a routine basis I would not recommend aspirin use in primary prevention. And it certainly should not be put in a polypill for mass use."

Still think they have any idea what they are talking about?